These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1635029

  • 21. Effect of Trypanosoma cruzi membrane components on the formation of the classical pathway C3 convertase.
    Kipnis TL, Tambourgi DV, Sucupira M, Dias-da-Silva W.
    Braz J Med Biol Res; 1986; 19(2):271-8. PubMed ID: 3548858
    [Abstract] [Full Text] [Related]

  • 22. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S, Krarup A, Sim RB, Inal JM, Ramirez MI.
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [Abstract] [Full Text] [Related]

  • 23. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
    Almeida IC, Milani SR, Gorin PA, Travassos LR.
    J Immunol; 1991 Apr 01; 146(7):2394-400. PubMed ID: 1706399
    [Abstract] [Full Text] [Related]

  • 24. Plasma membrane ATP receptors in Trypanosoma cruzi trypomastigotes.
    Inverso JA, Song Y, Santos-Buch CA.
    Receptor; 1995 Apr 01; 5(4):197-206. PubMed ID: 8840398
    [Abstract] [Full Text] [Related]

  • 25. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
    Isenman DE, Podack ER, Cooper NR.
    J Immunol; 1980 Jan 01; 124(1):326-31. PubMed ID: 7350230
    [Abstract] [Full Text] [Related]

  • 26. In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.
    Umekita LF, Mota I.
    Parasite Immunol; 1989 Sep 01; 11(5):561-6. PubMed ID: 2531362
    [Abstract] [Full Text] [Related]

  • 27. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum.
    Puentes SM, Dwyer DM, Bates PA, Joiner KA.
    J Immunol; 1989 Dec 01; 143(11):3743-9. PubMed ID: 2584716
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of macrophage-Trypanosoma cruzi interaction by concanavalin A and differential binding of bloodstream and culture forms to the macrophage surface.
    Zenian A, Kierszenbaum F.
    J Parasitol; 1982 Jun 01; 68(3):408-15. PubMed ID: 7047708
    [Abstract] [Full Text] [Related]

  • 29. Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.
    Ramírez-Toloza G, Ferreira A.
    Front Microbiol; 2017 Jun 01; 8():1667. PubMed ID: 28919885
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I, Sahu A, Friedman HM, Eisenberg RJ, Cohen GH, Lambris JD.
    J Immunol; 1997 Feb 15; 158(4):1763-71. PubMed ID: 9029114
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
    Imaz MS, Esteva M, Velázquez E, Ruiz AM, Segura EL, Marcipar AJ.
    Rev Latinoam Microbiol; 1997 Feb 15; 39(1-2):33-46. PubMed ID: 10932713
    [Abstract] [Full Text] [Related]

  • 32. [Trypanosoma cruzi: influence of human plasma on the morphogenesis of blood trypomastigotes in a cell-free culture media].
    Zaidenberg A, Tournier H, Schinella G, Buschiazzo H.
    Rev Latinoam Microbiol; 1995 Feb 15; 37(1):71-7. PubMed ID: 7784736
    [Abstract] [Full Text] [Related]

  • 33. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.
    Iida K, Whitlow MB, Nussenzweig V.
    J Exp Med; 1989 Mar 01; 169(3):881-91. PubMed ID: 2494292
    [Abstract] [Full Text] [Related]

  • 34. Parasite-derived trans-sialidase binds to heart tissue in Trypanosoma cruzi-infected animals.
    Alcântara-Neves NM, Ribeiro-dos-Santos R, Amor AL, Uemura H, Silva-Neto SJ, Eichinger D, Pontes-de-Carvalho L.
    Microb Pathog; 2004 Nov 01; 37(5):273-8. PubMed ID: 15519048
    [Abstract] [Full Text] [Related]

  • 35. Trypanosoma cruzi: circulating polysaccharide factors excreted in vitro and in vivo.
    Martín UO, Afchain D, Loyens M, Maidana C, Caprón A.
    Medicina (B Aires); 1989 Nov 01; 49(1):33-6. PubMed ID: 2517138
    [Abstract] [Full Text] [Related]

  • 36. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases.
    Joiner KA, daSilva WD, Rimoldi MT, Hammer CH, Sher A, Kipnis TL.
    J Biol Chem; 1988 Aug 15; 263(23):11327-35. PubMed ID: 3042767
    [Abstract] [Full Text] [Related]

  • 37. Identity of C3- and C5-receptors on lymphoid cells.
    Landen B, Dierich MP.
    J Immunol; 1979 Mar 15; 122(3):1015-7. PubMed ID: 448068
    [Abstract] [Full Text] [Related]

  • 38. Proteins anchored via glycosylphosphatidylinositol and solubilizing phospholipases in Trypanosoma cruzi.
    de Almeida ML, Heise N.
    Biol Res; 1993 Mar 15; 26(1-2):285-312. PubMed ID: 7670541
    [Abstract] [Full Text] [Related]

  • 39. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    Strunk RC, Giclas PC.
    J Immunol; 1980 Feb 15; 124(2):520-6. PubMed ID: 7356706
    [No Abstract] [Full Text] [Related]

  • 40. Comparative studies on surface antigenicity of Trypanosoma cruzi trypomastigotes from infected mouse blood and infected L-cell cultures.
    Kanbara H, Nakabayashi T.
    Biken J; 1985 Dec 15; 28(3-4):71-7. PubMed ID: 3914887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.